Viewing Study NCT04677933


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2025-12-30 @ 1:37 PM
Study NCT ID: NCT04677933
Status: COMPLETED
Last Update Posted: 2020-12-24
First Post: 2020-11-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002
Sponsor: OliPass Australia Pty Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module